Risperdal

Irritability, Autism, Schizophrenia + 10 more

Treatment

6 FDA approvals

20 Active Studies for Risperdal

What is Risperdal

Risperidone

The Generic name of this drug

Treatment Summary

Risperidone is a medication used to treat mental health conditions like schizophrenia and bipolar disorder. It is a type of antipsychotic medication that works by blocking certain chemical receptors in the brain, reducing the overactivity of certain pathways. Risperidone binds very strongly to certain receptors in the brain, and has lesser activity at other targets which may contribute to side effects.

Risperidone

is the brand name

image of different drug pills on a surface

Risperdal Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Risperidone

Risperidone

1993

522

Approved as Treatment by the FDA

Risperidone, also known as Risperidone, is approved by the FDA for 6 uses such as Bipolar 1 Disorder and Acute Mania .

Bipolar 1 Disorder

Acute Mania

Mixed manic depressive episode

Common Cold

Bipolar Disorder

Bipolar Disorder

Effectiveness

How Risperdal Affects Patients

Risperidone works by reducing the activity of certain chemicals in the brain like dopamine and serotonin. It does this by attaching itself to certain receptors in the brain, with a higher binding affinity for serotonin receptors than dopamine receptors. This makes it different from other antipsychotic drugs which tend to attach more strongly to dopamine receptors. This difference is thought to be the reason why risperidone causes fewer side effects than its predecessors.

How Risperdal works in the body

Risperidone works by stopping too much dopamine and serotonin from being released in the brain. Excess dopamine and serotonin can cause delusions, hallucinations and other symptoms of schizophrenia. Risperidone is able to block these receptors for a short time, reducing the amount of dopamine and serotonin in the brain. This helps to reduce the symptoms of schizophrenia without causing side effects. Risperidone also blocks other receptors such as alpha-1, alpha-2, and histamine, which may also help reduce symptoms of schizophrenia, though the exact mechanism of action is not yet known.

When to interrupt dosage

The measure of Risperdal is contingent upon the determined issue, including Psychotic Disorders, Irritability and Acute Mania. The quantity of dosage changes, as per the procedure of delivery (e.g. Subcutaneous or Solution) presented in the table below.

Condition

Dosage

Administration

Autism

, 0.5 mg, 1.0 mg, 2.0 mg, 4.0 mg, 3.0 mg, 0.25 mg, 1.0 mg/mL, 25.0 mg, 37.5 mg, 50.0 mg, 12.5 mg, 5.0 mg, 12.5 mg/mL, 37.5 mg/mL, 50.0 mg/mL, 25.0 mg/mL, 900.0 mg/mL, 1200.0 mg/mL, 120.0 mg, 90.0 mg

, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Tablet, coated, Tablet, coated - Oral, Intramuscular, Injection, powder, for suspension, extended release; Kit, Injection, powder, for suspension, extended release; Kit - Intramuscular, Kit, Kit - Subcutaneous, Subcutaneous, Kit; Powder, for suspension, Kit; Powder, for suspension - Subcutaneous, Injection, powder, for suspension, extended release; Kit - Subcutaneous

Schizophrenia

, 0.5 mg, 1.0 mg, 2.0 mg, 4.0 mg, 3.0 mg, 0.25 mg, 1.0 mg/mL, 25.0 mg, 37.5 mg, 50.0 mg, 12.5 mg, 5.0 mg, 12.5 mg/mL, 37.5 mg/mL, 50.0 mg/mL, 25.0 mg/mL, 900.0 mg/mL, 1200.0 mg/mL, 120.0 mg, 90.0 mg

, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Tablet, coated, Tablet, coated - Oral, Intramuscular, Injection, powder, for suspension, extended release; Kit, Injection, powder, for suspension, extended release; Kit - Intramuscular, Kit, Kit - Subcutaneous, Subcutaneous, Kit; Powder, for suspension, Kit; Powder, for suspension - Subcutaneous, Injection, powder, for suspension, extended release; Kit - Subcutaneous

Acute Coryza

, 0.5 mg, 1.0 mg, 2.0 mg, 4.0 mg, 3.0 mg, 0.25 mg, 1.0 mg/mL, 25.0 mg, 37.5 mg, 50.0 mg, 12.5 mg, 5.0 mg, 12.5 mg/mL, 37.5 mg/mL, 50.0 mg/mL, 25.0 mg/mL, 900.0 mg/mL, 1200.0 mg/mL, 120.0 mg, 90.0 mg

, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Tablet, coated, Tablet, coated - Oral, Intramuscular, Injection, powder, for suspension, extended release; Kit, Injection, powder, for suspension, extended release; Kit - Intramuscular, Kit, Kit - Subcutaneous, Subcutaneous, Kit; Powder, for suspension, Kit; Powder, for suspension - Subcutaneous, Injection, powder, for suspension, extended release; Kit - Subcutaneous

Schizophrenia

, 0.5 mg, 1.0 mg, 2.0 mg, 4.0 mg, 3.0 mg, 0.25 mg, 1.0 mg/mL, 25.0 mg, 37.5 mg, 50.0 mg, 12.5 mg, 5.0 mg, 12.5 mg/mL, 37.5 mg/mL, 50.0 mg/mL, 25.0 mg/mL, 900.0 mg/mL, 1200.0 mg/mL, 120.0 mg, 90.0 mg

, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Tablet, coated, Tablet, coated - Oral, Intramuscular, Injection, powder, for suspension, extended release; Kit, Injection, powder, for suspension, extended release; Kit - Intramuscular, Kit, Kit - Subcutaneous, Subcutaneous, Kit; Powder, for suspension, Kit; Powder, for suspension - Subcutaneous, Injection, powder, for suspension, extended release; Kit - Subcutaneous

Bipolar Disorder

, 0.5 mg, 1.0 mg, 2.0 mg, 4.0 mg, 3.0 mg, 0.25 mg, 1.0 mg/mL, 25.0 mg, 37.5 mg, 50.0 mg, 12.5 mg, 5.0 mg, 12.5 mg/mL, 37.5 mg/mL, 50.0 mg/mL, 25.0 mg/mL, 900.0 mg/mL, 1200.0 mg/mL, 120.0 mg, 90.0 mg

, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Tablet, coated, Tablet, coated - Oral, Intramuscular, Injection, powder, for suspension, extended release; Kit, Injection, powder, for suspension, extended release; Kit - Intramuscular, Kit, Kit - Subcutaneous, Subcutaneous, Kit; Powder, for suspension, Kit; Powder, for suspension - Subcutaneous, Injection, powder, for suspension, extended release; Kit - Subcutaneous

Behcet Syndrome

, 0.5 mg, 1.0 mg, 2.0 mg, 4.0 mg, 3.0 mg, 0.25 mg, 1.0 mg/mL, 25.0 mg, 37.5 mg, 50.0 mg, 12.5 mg, 5.0 mg, 12.5 mg/mL, 37.5 mg/mL, 50.0 mg/mL, 25.0 mg/mL, 900.0 mg/mL, 1200.0 mg/mL, 120.0 mg, 90.0 mg

, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Tablet, coated, Tablet, coated - Oral, Intramuscular, Injection, powder, for suspension, extended release; Kit, Injection, powder, for suspension, extended release; Kit - Intramuscular, Kit, Kit - Subcutaneous, Subcutaneous, Kit; Powder, for suspension, Kit; Powder, for suspension - Subcutaneous, Injection, powder, for suspension, extended release; Kit - Subcutaneous

Alzheimer's Disease

, 0.5 mg, 1.0 mg, 2.0 mg, 4.0 mg, 3.0 mg, 0.25 mg, 1.0 mg/mL, 25.0 mg, 37.5 mg, 50.0 mg, 12.5 mg, 5.0 mg, 12.5 mg/mL, 37.5 mg/mL, 50.0 mg/mL, 25.0 mg/mL, 900.0 mg/mL, 1200.0 mg/mL, 120.0 mg, 90.0 mg

, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Tablet, coated, Tablet, coated - Oral, Intramuscular, Injection, powder, for suspension, extended release; Kit, Injection, powder, for suspension, extended release; Kit - Intramuscular, Kit, Kit - Subcutaneous, Subcutaneous, Kit; Powder, for suspension, Kit; Powder, for suspension - Subcutaneous, Injection, powder, for suspension, extended release; Kit - Subcutaneous

Common Cold

, 0.5 mg, 1.0 mg, 2.0 mg, 4.0 mg, 3.0 mg, 0.25 mg, 1.0 mg/mL, 25.0 mg, 37.5 mg, 50.0 mg, 12.5 mg, 5.0 mg, 12.5 mg/mL, 37.5 mg/mL, 50.0 mg/mL, 25.0 mg/mL, 900.0 mg/mL, 1200.0 mg/mL, 120.0 mg, 90.0 mg

, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Tablet, coated, Tablet, coated - Oral, Intramuscular, Injection, powder, for suspension, extended release; Kit, Injection, powder, for suspension, extended release; Kit - Intramuscular, Kit, Kit - Subcutaneous, Subcutaneous, Kit; Powder, for suspension, Kit; Powder, for suspension - Subcutaneous, Injection, powder, for suspension, extended release; Kit - Subcutaneous

Schizophrenia

, 0.5 mg, 1.0 mg, 2.0 mg, 4.0 mg, 3.0 mg, 0.25 mg, 1.0 mg/mL, 25.0 mg, 37.5 mg, 50.0 mg, 12.5 mg, 5.0 mg, 12.5 mg/mL, 37.5 mg/mL, 50.0 mg/mL, 25.0 mg/mL, 900.0 mg/mL, 1200.0 mg/mL, 120.0 mg, 90.0 mg

, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Tablet, coated, Tablet, coated - Oral, Intramuscular, Injection, powder, for suspension, extended release; Kit, Injection, powder, for suspension, extended release; Kit - Intramuscular, Kit, Kit - Subcutaneous, Subcutaneous, Kit; Powder, for suspension, Kit; Powder, for suspension - Subcutaneous, Injection, powder, for suspension, extended release; Kit - Subcutaneous

responsive to first treatment

, 0.5 mg, 1.0 mg, 2.0 mg, 4.0 mg, 3.0 mg, 0.25 mg, 1.0 mg/mL, 25.0 mg, 37.5 mg, 50.0 mg, 12.5 mg, 5.0 mg, 12.5 mg/mL, 37.5 mg/mL, 50.0 mg/mL, 25.0 mg/mL, 900.0 mg/mL, 1200.0 mg/mL, 120.0 mg, 90.0 mg

, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Tablet, coated, Tablet, coated - Oral, Intramuscular, Injection, powder, for suspension, extended release; Kit, Injection, powder, for suspension, extended release; Kit - Intramuscular, Kit, Kit - Subcutaneous, Subcutaneous, Kit; Powder, for suspension, Kit; Powder, for suspension - Subcutaneous, Injection, powder, for suspension, extended release; Kit - Subcutaneous

Irritability

, 0.5 mg, 1.0 mg, 2.0 mg, 4.0 mg, 3.0 mg, 0.25 mg, 1.0 mg/mL, 25.0 mg, 37.5 mg, 50.0 mg, 12.5 mg, 5.0 mg, 12.5 mg/mL, 37.5 mg/mL, 50.0 mg/mL, 25.0 mg/mL, 900.0 mg/mL, 1200.0 mg/mL, 120.0 mg, 90.0 mg

, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Tablet, coated, Tablet, coated - Oral, Intramuscular, Injection, powder, for suspension, extended release; Kit, Injection, powder, for suspension, extended release; Kit - Intramuscular, Kit, Kit - Subcutaneous, Subcutaneous, Kit; Powder, for suspension, Kit; Powder, for suspension - Subcutaneous, Injection, powder, for suspension, extended release; Kit - Subcutaneous

Psychotic Disorders

, 0.5 mg, 1.0 mg, 2.0 mg, 4.0 mg, 3.0 mg, 0.25 mg, 1.0 mg/mL, 25.0 mg, 37.5 mg, 50.0 mg, 12.5 mg, 5.0 mg, 12.5 mg/mL, 37.5 mg/mL, 50.0 mg/mL, 25.0 mg/mL, 900.0 mg/mL, 1200.0 mg/mL, 120.0 mg, 90.0 mg

, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Tablet, coated, Tablet, coated - Oral, Intramuscular, Injection, powder, for suspension, extended release; Kit, Injection, powder, for suspension, extended release; Kit - Intramuscular, Kit, Kit - Subcutaneous, Subcutaneous, Kit; Powder, for suspension, Kit; Powder, for suspension - Subcutaneous, Injection, powder, for suspension, extended release; Kit - Subcutaneous

Bipolar Disorder

, 0.5 mg, 1.0 mg, 2.0 mg, 4.0 mg, 3.0 mg, 0.25 mg, 1.0 mg/mL, 25.0 mg, 37.5 mg, 50.0 mg, 12.5 mg, 5.0 mg, 12.5 mg/mL, 37.5 mg/mL, 50.0 mg/mL, 25.0 mg/mL, 900.0 mg/mL, 1200.0 mg/mL, 120.0 mg, 90.0 mg

, Oral, Tablet, film coated, Tablet, film coated - Oral, Tablet, Tablet - Oral, Solution, Solution - Oral, Tablet, orally disintegrating, Tablet, orally disintegrating - Oral, Tablet, coated, Tablet, coated - Oral, Intramuscular, Injection, powder, for suspension, extended release; Kit, Injection, powder, for suspension, extended release; Kit - Intramuscular, Kit, Kit - Subcutaneous, Subcutaneous, Kit; Powder, for suspension, Kit; Powder, for suspension - Subcutaneous, Injection, powder, for suspension, extended release; Kit - Subcutaneous

Warnings

Risperdal has two contraindications. It should not be taken when encountering any of the conditions listed in the following table.

Risperdal Contraindications

Condition

Risk Level

Notes

Pulse Frequency

Do Not Combine

Severe Hypersensitivity Reactions

Do Not Combine

Risperidone may interact with Pulse Frequency

There are 20 known major drug interactions with Risperdal.

Common Risperdal Drug Interactions

Drug Name

Risk Level

Description

Acepromazine

Major

Risperidone may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Acepromazine.

Alfuzosin

Major

Risperidone may increase the hypotensive activities of Alfuzosin.

Amisulpride

Major

Risperidone may increase the antipsychotic activities of Amisulpride.

Aripiprazole

Major

Risperidone may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Aripiprazole.

Aripiprazole lauroxil

Major

Risperidone may increase the orthostatic hypotensive, hypotensive, and antihypertensive activities of Aripiprazole lauroxil.

Risperdal Toxicity & Overdose Risk

Overdosing on Levetiracetam can cause fatigue, body spasms, rapid heart rate, slow heart rate, and seizures. The lethal dose in rats is 57.7 mg/kg if given orally or 34 mg/kg if given intravenously.

image of a doctor in a lab doing drug, clinical research

Risperdal Novel Uses: Which Conditions Have a Clinical Trial Featuring Risperdal?

359 active studies are currently being conducted to evaluate the potential of Risperdal to provide relief from Acute Mania, Bipolar Disorder and Autism.

Condition

Clinical Trials

Trial Phases

Schizophrenia

97 Actively Recruiting

Phase 3, Not Applicable, Early Phase 1, Phase 4, Phase 1, Phase 2

Behcet Syndrome

1 Actively Recruiting

Not Applicable

Schizophrenia

32 Actively Recruiting

Early Phase 1, Not Applicable, Phase 4

Schizophrenia

0 Actively Recruiting

Bipolar Disorder

0 Actively Recruiting

Irritability

8 Actively Recruiting

Phase 2, Not Applicable, Early Phase 1, Phase 4

Psychotic Disorders

0 Actively Recruiting

Acute Coryza

1 Actively Recruiting

Not Applicable

Common Cold

0 Actively Recruiting

Autism

7 Actively Recruiting

Phase 2, Not Applicable

Bipolar Disorder

0 Actively Recruiting

Alzheimer's Disease

15 Actively Recruiting

Not Applicable, Phase 2, Phase 1

responsive to first treatment

0 Actively Recruiting

Risperdal Reviews: What are patients saying about Risperdal?

4

Patient Review

2/13/2022

Risperdal for Bipolar Disorder in Remission

I definitely notice a difference in my mood stability when I'm on this medication. Without it, I tend to swing to more extreme emotions; however, while on the medication, I feel much more even-keeled.

4

Patient Review

8/13/2022

Risperdal for Schizophrenia

It can be tough to keep my eyes open on this medication, but I've gotten used to it. The only other downside is that sidewalk walking and being around cars can be dangerous if my eyes close for even a few seconds. But overall, this med works great for my schizophrenia.

4

Patient Review

9/4/2019

Risperdal for Bipolar Disorder in Remission

I felt a little dizzy on the first day taking risperidone, but that went away quickly. After a month of taking it, I've noticed my focus and concentration have improved significantly. The only downside is that I feel a little tired, but it's not too bad.

4

Patient Review

8/13/2022

Risperdal for Schizophrenia

It can be tough to keep my eyes open when I'm on this medication, but I've gotten used to it. The main thing is that it really helps with my schizophrenia.

4

Patient Review

9/4/2019

Risperdal for Bipolar Disorder in Remission

I felt a little dizzy after taking the medication the first day, but that went away. I've been on it for 4 weeks now and have definitely noticed an improvement in my focus and concentration. The medicine makes me feel a little tired, but it's not too bad.

4

Patient Review

2/13/2022

Risperdal for Bipolar Disorder in Remission

Before taking this medication, my mood swings were really severe. Now that I'm on it, I don't feel those extremes as much. It's helped me a lot.

3.7

Patient Review

11/3/2022

Risperdal for Bipolar Disorder in Remission

While this medication was effective in treating my schizophrenia, it unfortunately also rendered me infertile. In 12 years of use, I have tried to impregnate 100 ladies and have been unsuccessful. This is a serious fertility problem for males.

3.7

Patient Review

3/19/2022

Risperdal for Additional Medications to Treat Depression

This helps me a lot with my anxiety but I sometimes find the drowsy side effects tough to manage.

3.7

Patient Review

4/30/2022

Risperdal for Additional Medications to Treat Depression

I find it hard to wakeup in the next morning when I'm taking this drug at night. But it improved my condition to better.

3.7

Patient Review

11/3/2022

Risperdal for Bipolar Disorder in Remission

While this medication was successful in treating my schizophrenia, I unfortunately experienced serious fertility problems as a result of taking it. In twelve years, I tried to impregnate one hundred ladies and was unsuccessful.

3.7

Patient Review

3/19/2022

Risperdal for Additional Medications to Treat Depression

This drug does a great job at helping me manage my anxiety. The only downside is that I sometimes feel really drowsy as a result of taking it.

3.7

Patient Review

4/30/2022

Risperdal for Additional Medications to Treat Depression

I find it hard to wakeup in the next morning when I'm taking this drug at night. But it improved my condition overall.

3

Patient Review

10/9/2022

Risperdal for Bipolar Depression

I switched to Risperidone recently after taking Lamictal for six years. I'm glad to be off of Lamictal, but I find that Risperidone has made me feel emotionless and unmotivated. My anxiety has also increased since starting this medication, so I may ask my doctor to switch me back.

3

Patient Review

10/9/2022

Risperdal for Bipolar Depression

I switched to Risperidone from Lamictal, and while I'm glad to be off of the latter, I feel much worse on the former. I don't laugh anymore, anxiety has increased, and generally speaking I just have zero motivation. Going to speak with my doctor about getting off of it soon.

2.7

Patient Review

10/14/2022

Risperdal for Bipolar Depression

This medicine made me feel incredibly lethargic and uncoordinated. I would definitely not recommend it to anyone.

2.7

Patient Review

4/26/2019

Risperdal for Bipolar I Disorder with Most Recent Episode Mixed

I just started taking this medication and I'm coming off Abilify. I've been taking it for 3 days and so far, I had a very deep sleep last night but the first night I had insomnia. I'm starting to feel a little sedated. Will come back to review it when I've taken it for a longer period of time.

2.7

Patient Review

10/14/2022

Risperdal for Bipolar Depression

This medicine made me feel awful. I felt like I needed to stay in bed all day and could hardly function. The dizziness and muscle jerks were really unpleasant.

2.7

Patient Review

4/26/2019

Risperdal for Bipolar I Disorder with Most Recent Episode Mixed

I'm just starting to take this medication, and so far I've had one good night's sleep and one bad night's sleep. I'm also feeling a little sedated during the day. I'll come back and update my review after taking it for a longer period of time. Right now, I'm concerned about potential weight gain side effects that I've read about online.

2.3

Patient Review

5/26/2022

Risperdal for Bipolar Depression

I wouldn't recommend this to someone who struggles with anxiety on a daily basis, as it unfortunately worsened my anxiety and caused me to have panic attacks. It did help take away the sharp edges of emotions, but for me it wasn't worth the increased anxiety in return.

2.3

Patient Review

5/26/2022

Risperdal for Bipolar Depression

I would not recommend this to people who already suffer from anxiety. It unfortunately made my anxiety worse and I began having panic attacks every day. While it did help me think more clearly, the increased anxiety was not worth the trade-off.

2.3

Patient Review

7/28/2022

Risperdal for Additional Medications to Treat Depression

The medicine increased my anxiety and restlessness to an almost unbearable level.

2.3

Patient Review

7/28/2022

Risperdal for Additional Medications to Treat Depression

This medication unfortunately made my anxiety and restlessness much worse.

2

Patient Review

5/5/2021

Risperdal for Mania associated with Bipolar Disorder

I was only on a low dose, but it made me so dizzy and sick that I couldn't even stand up.

2

Patient Review

5/5/2021

Risperdal for Mania associated with Bipolar Disorder

I didn't have a good experience with this medication. I was on a low dose (.5 mg) but it made me so dizzy and sick that I couldn't even stand up or keep anything down.

2

Patient Review

3/6/2019

Risperdal for Mania associated with Bipolar Disorder

2

Patient Review

3/6/2019

Risperdal for Mania associated with Bipolar Disorder

1

Patient Review

9/25/2019

Risperdal for Mania associated with Bipolar Disorder

I started taking this medication when I was 15 and it worked well for a while, but after six years I started feeling my symptoms come back. I decided to try lithium as well and it has been working wonders!

1

Patient Review

9/25/2019

Risperdal for Mania associated with Bipolar Disorder

I started taking this when I was 15 and it worked well for the first few years, but then I began to feel my symptoms coming back. I've been on lithium as well for the past year and I haven't felt this good ever! Definitely recommend these two medications combined.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about risperdal

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the side effect of Risperdal?

"To minimize dizziness and lightheadedness, get up slowly from a sitting or lying position.

Drowsiness, dizziness, lightheadedness, drooling, nausea, weight gain, or tiredness may occur. These effects can persist or worsen- tell your doctor or pharmacist promptly. Dizziness and lightheadedness can increase the risk of falling, so get up slowly when rising from a sitting or lying position."

Answered by AI

What is the drug Risperdal used for?

"This medication is used to treat conditions such asschizophrenia, bipolar disorder, or autism-related irritability. It is not to be used for behavioral issues in adults with dementia. A prescription from a doctor is required to obtain this medication."

Answered by AI

Is Risperdal a Xanax?

"Risperdal is usually given to people with schizophrenia, bipolar mania, and autism. Xanax is mostly given to people who have panic attacks and anxiety disorders. Risperdal and Xanax work differently and are not in the same drug class."

Answered by AI

How does Risperdal make you feel?

"It can take several days or even months for risperidone to work. Common side effects include feeling sleepy, problems with your movement and headaches. You may also feel more hungry than usual, which can lead to weight gain."

Answered by AI

Clinical Trials for Risperdal

Image of Biomedical Research Imaging Center (BRIC) at UNC in Chapel Hill, United States.

Kurvelo for Irritability in Adolescents

12 - 16
Female
Chapel Hill, NC

Purpose: Risk of severe psychopathology increases dramatically during adolescence, especially for females. Changes in ovarian steroids across the menstrual cycle produce windows of vulnerability to mood disturbances, particularly during the abrupt withdrawal of estradiol (E2) and progesterone (P4) prior to menses onset. Irrefutable evidence links stress with affective symptoms, potentially mediated by E2-related modifications of frontolimbic connectivity and prefrontal gamma-aminobutyric acid (GABA) inhibitory signaling. The primary objective of this project is to empirically test the impact of E2 and P4 change on vulnerable brain networks associated with irritability and other depressive symptoms in female adolescents at risk of suicide. Participants: The investigators will enroll 50 female adolescents ages 12-16 who are at risk of suicide (i.e., moderate depressive symptoms), and are eligible to receive oral contraceptives and undergo MRI imaging. Procedure: Using a randomized, placebo-controlled, cross-over design, participants will be studied under two conditions: 8 weeks of E2 and P4 stabilization (continuous combined oral contraceptive (COC) to prevent perimenstrual withdrawal) and 8 weeks of placebo, with a 1-month washout after each condition. Each condition will include: 1) daily samples of E2 and P4 urinary metabolites, 2) daily symptom ratings(e.g., irritability, negative affect and suicidal thoughts and behaviors (STBs)), and 3) a neuroimaging session with MRI and magnetic resonance spectroscopy (MRS).

Phase 4
Waitlist Available

Biomedical Research Imaging Center (BRIC) at UNC (+1 Sites)

Elizabeth Andersen, PhD

Have you considered Risperdal clinical trials?

We made a collection of clinical trials featuring Risperdal, we think they might fit your search criteria.
Go to Trials

Have you considered Risperdal clinical trials?

We made a collection of clinical trials featuring Risperdal, we think they might fit your search criteria.
Go to Trials

Have you considered Risperdal clinical trials?

We made a collection of clinical trials featuring Risperdal, we think they might fit your search criteria.
Go to Trials